NCT05916911 2024-02-07
Evaluation Of The Efficacy Of The Combination Of GLIZIGENĀ® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Catalysis SL
Phase 4 Unknown